| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/29/2013 | CN202951403U Production device for decoloring crude product of vitamin B6 |
| 05/29/2013 | CN103124724A Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use |
| 05/29/2013 | CN103124723A Novel microbiocides |
| 05/29/2013 | CN103121967A Intermediate of solid-phase time-resolved fluorescence immunoassay chelating agent and method for preparing intermediate |
| 05/29/2013 | CN103121966A Method for directionally synthesizing (4-chlorphenyl)-(pyridine-2-base)-methanol |
| 05/29/2013 | CN102066327B Iminopyridine derivatives and use thereof |
| 05/29/2013 | CN101696221B Substituted isoxazoles as fungicides |
| 05/29/2013 | CN101628847B Organic electroluminescence device and anthracene derivative |
| 05/29/2013 | CN101466710B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/29/2013 | CN101184734B Compound and methods of treating cell proliferation disorders |
| 05/28/2013 | US8450371 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/28/2013 | US8450349 Long acting dual release product containing carbinoxamine and pseudoephedrine |
| 05/28/2013 | US8450348 Such as 3-[6-(4-Chloro-phenoxy)-hexylamino]-4-(pyridin-4-ylamino)-cyclobut-3-ene-1,2-dione; cancer, tumors; reduced side effects |
| 05/28/2013 | US8450347 Administering a protein fraction, digestible carbohydrates, and a combination of folate, and one of vitamin B6 and vitamin B12. |
| 05/28/2013 | US8450346 Azetidine derivatives as FAAH inhibitors |
| 05/28/2013 | US8449936 Flavor molecules |
| 05/28/2013 | CA2790294C .alpha.-crystalline form of carbabenzpyride |
| 05/28/2013 | CA2716352C Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 05/28/2013 | CA2683768C Method of synthesizing camptothecin-relating compounds |
| 05/28/2013 | CA2561897C Thio-substituted biaryl-methanesulfinyl derivatives |
| 05/28/2013 | CA2558647C Insecticidal n-substituted sulfoximines |
| 05/28/2013 | CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia |
| 05/28/2013 | CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |
| 05/23/2013 | WO2013074517A1 Kinase protein binding inhibitors |
| 05/23/2013 | WO2013073577A1 Dihydroxy aromatic heterocyclic compound |
| 05/23/2013 | WO2013072470A1 Anions and derived salts with high dissociation in non-protogenic solvents |
| 05/23/2013 | WO2013026790A9 Luminescent lanthanide chelates having three chromophores and their use |
| 05/23/2013 | US20130131350 Pyridin-2yl sulfanyl acid esters and process for the preparation thereof |
| 05/23/2013 | US20130131321 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY |
| 05/23/2013 | US20130131122 Fluro substituted Omega-Carboxyaryl Diphenyl Urea for the Treatment and Prevention of Diseases and Conditions |
| 05/23/2013 | US20130131092 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 05/23/2013 | US20130131085 Cytochrome p450 oxidase inhibitors and uses thereof |
| 05/23/2013 | US20130131056 Positive allosteric modulators (pam) |
| 05/23/2013 | US20130131036 Novel trpv3 modulators |
| 05/23/2013 | CA2855021A1 Process for the preparation of roflumilast |
| 05/22/2013 | EP2594558A1 Complex compound and optical recording medium containing same |
| 05/22/2013 | EP2594557A1 Substituted aminopropionic derivatives as neprilysin inhibitors |
| 05/22/2013 | EP2594556A1 Substituted aminopropionic derivatives as neprilysin inhibitors |
| 05/22/2013 | EP2594550A1 Method for oxidizing alcohols |
| 05/22/2013 | EP2593434A1 Pyridine compounds as sodium channel blockers |
| 05/22/2013 | EP2593433A2 N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels |
| 05/22/2013 | EP2593432A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| 05/22/2013 | EP2593431A2 Chemical compounds |
| 05/22/2013 | EP2593426A1 1-hydroxyimino-3-phenyl-propanes |
| 05/22/2013 | EP2592934A1 Novel dihydropyridin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists |
| 05/22/2013 | CN1993339B Aromatic compounds |
| 05/22/2013 | CN103118680A Heteroarylmethyl amides |
| 05/22/2013 | CN103113855A Low-temperature magnetic refrigeration metal-organic framework material as well as preparation method and use thereof |
| 05/22/2013 | CN103113292A Novel dapoxetine nicotinamide eutectic crystal form |
| 05/22/2013 | CN103113291A Synthesis method of 3-position alkenyl pyridine derivatives |
| 05/22/2013 | CN103113247A Method for preparing amino-acid ester |
| 05/22/2013 | CN103113174A Preparation method of phenolic compounds |
| 05/22/2013 | CN103111318A Supported catalyst with ruthenium (III) as active center and preparation method of catalyst |
| 05/22/2013 | CN102304082B Synthesis method of 2-chloro-4-(piperidylmethyl)pyridine |
| 05/22/2013 | CN102127030B 4-(substituted-1,3-dialkynyl)-4-(trifluoromethyl)benzo-1,4-dihydroxazole-2-one compounds and preparation method and applications thereof |
| 05/22/2013 | CN102060757B Acylhydrazone Schiff alkali compound and preparation method and application thereof |
| 05/22/2013 | CN102036959B Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof |
| 05/22/2013 | CN101921220B Pharmaceutical compositions for treating diseases with bone mass loss having EP4 agonist as the active ingredient |
| 05/22/2013 | CN101835756B 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive MGLUR2 -receptor modulators |
| 05/21/2013 | US8445689 Pesticides |
| 05/21/2013 | US8445687 Process for the preparation of a RAF kinase inhibitor and intermediates for use in the process |
| 05/21/2013 | US8445685 Process to prepare pioglitazone via several novel intermediates |
| 05/21/2013 | US8445683 Porphyrin compounds comprising one or more pyridone moieties |
| 05/21/2013 | US8445507 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
| 05/21/2013 | CA2699598C 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3-alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides |
| 05/21/2013 | CA2573223C Aromatic compound |
| 05/16/2013 | WO2013071001A1 Treatment of ovarian cancer with benzylidenebenzohydrazides |
| 05/16/2013 | WO2013070660A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| 05/16/2013 | WO2013070550A1 Environmentally friendly corrosion inhibitors |
| 05/16/2013 | WO2013070118A1 (3k,4k,58)-4-acylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-ene carboxylic acids, esters thereof and method of use |
| 05/16/2013 | WO2013069721A1 Metal complex, and adsorbent, absorbent and separator formed of same |
| 05/16/2013 | WO2013068785A1 Indanone and indandione derivatives and heterocyclic analogs |
| 05/16/2013 | US20130123506 Substituted enaminocarbonyl compounds |
| 05/16/2013 | US20130123505 Method for producing carboxylic acid amide |
| 05/16/2013 | US20130123496 Aryl urea derivatives as n-formyl peptide receptors like-1 (fprl-1) receptor modulators |
| 05/16/2013 | US20130123304 Pyridine non-classical cannabinoid compounds and related methods of use |
| 05/16/2013 | US20130123247 Arthropodicidal anthranilamides |
| 05/16/2013 | US20130123234 Aryl- or Heteroaryl-Substituted Benzene Compounds |
| 05/16/2013 | US20130123225 Inhibition of bacterial biofilms with aryl carbamates |
| 05/16/2013 | US20130121919 Histone acetyltransferase activators and uses thereof |
| 05/16/2013 | US20130119355 Styryl-based compound, composition containing styryl-based compound, and organic light emitting diode including styryl-based compound |
| 05/16/2013 | DE112011101527T5 Synthese von vierfach koordinierten Gold-Komplexen und deren Anwendungen in lichtemittierenden Vorrichtungen Synthesis of four-coordinate gold complexes and their applications in light-emitting devices |
| 05/16/2013 | DE112011101526T5 Synthese von vierfach koordinierten Palladium-Komplexen und deren Anwendungen in lichtemittierenden Vorrichtungen Synthesis of four-coordinated palladium complexes and their applications in light-emitting devices |
| 05/16/2013 | CA2855249A1 Treatment of ovarian cancer with benzylidenebenzohydrazides |
| 05/16/2013 | CA2854836A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| 05/16/2013 | CA2846979A1 Environmentally friendly corrosion inhibitors |
| 05/15/2013 | EP2592905A1 Compound, charge transporting material and organic electroluminescent element |
| 05/15/2013 | EP2590947A1 Intermediates and process for preparing a thrombin specific inhibitor |
| 05/15/2013 | EP2590946A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 05/15/2013 | EP2590945A2 Serine protease inhibitors |
| 05/15/2013 | EP2590930A1 Spirocyclically substituted 1,3-propane dioxide derivatives, methods for the production thereof and use of the same as medicament |
| 05/15/2013 | EP2590929A1 Aryloxy-alkylene substituted hydroxyphenyl hexynoic acids, methods for the production thereof and use of the same as medicament |
| 05/15/2013 | CN103108866A Cyclohexane derivative compound |
| 05/15/2013 | CN103102301A Preparation method of substituted pyridine-2-sulfonium salt |
| 05/15/2013 | CN103102296A Method for synthesizing isothiocyanate by two steps |
| 05/15/2013 | CN103102232A Styryl-based compound, composition containing styryl-based compound, and organic light emitting diode including styryl-based compound |
| 05/15/2013 | CN103100372A Metal-organic framework material for methane adsorption and storage and preparation method thereof |
| 05/15/2013 | CN102344411B Method for preparing 2,6-dimethoxy-3,5-diamido-pyridine hydrochloride |
| 05/15/2013 | CN101808994B Compounds and methods for kinase modulation, and indications therefor |